Orchid Pharma Ltd. benchmarking: Performance to industry peers

Financial

	Orchid Pharma	Zota Health Care	Novartis
Operational Metrics
Financials
5 yr Average ROE	4.49 %	1.99 %	8.11 %
5yr average Equity Multiplier	1.61	1.84	2.72
5yr Average Asset Turnover Ratio	0.5	0.91	0.18
5yr Avg Net Profit Margin	0.56 %	-4.95 %	17.12 %
Price to Book	3.0	5.6	4.49
P/E	188.01	0.0	39.43
5yr Avg Cash Conversion Cycle	52.03 Days	40.5 Days	-23.33 Days
Inventory Days	112.47 Days	91.82 Days	44.27 Days
Days Receivable	86.58 Days	42.2 Days	38.18 Days
Days Payable	159.29 Days	92.36 Days	124.28 Days
5yr Average Interest Coverage Ratio	3.01	5.98	65.43
5yr Avg ROCE	3.08 %	-2.72 %	5.91 %
5yr Avg Operating Profit Margin	11.84 %	3.69 %	15.15 %
5 yr average Debt to Equity	0.37	0.04	0.0
5yr CAGR Net Profit	n/a	206.06 %	37.01 %
5yr Average Return on Assets	1.2 %	-3.4 %	3.13 %
Shareholdings
Promoter Holding	69.84 %	49.38 %	70.68 %
Share Pledged by Promoters	0.0	0.26 %	0.0
Change in Promoter Holding (3 Yrs)	-20.12 %	-18.74 %	0.0
Change in Mutual Fund Holding (3 Yrs)	16.98 %	0.37 %	0.0

	Orchid Pharma	Zota Health Care	Novartis
Product Wise Break-Up	Product Wise Break-Up Oral Formulations 72.44 Sterile 27.56 Retail Pharmacy 0 Export 0 0 0	Product Wise Break-Up 0 Export 10.89 Marketing 21.65 Sterile 0 Pharmacy 63.56 Oral Formulations 0 Others 3.9	Product Wise Break-Up Wholesale of pharmaceuticals and medical goods 100.0 Export 0 0 Sterile 0 Retail Pharmacy 0 Oral Formulations 0
Location Wise Break-Up	Location Wise Break-Up India 19.9 Rest of the World 0 Others 80.1	Location Wise Break-Up Rest of the World 7.0 India 93.0	Location Wise Break-Up Rest of the World 0 India 100.0
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise Others 100	-	-